Diagnoplex SA

Lausanne, Switzerland



DiagnoplexSA, Lausanne, Switzerland

Developing and manufacturing COLOX™, a minimally invasive, blood-based, laboratory developed screening test for colorectal cancer.

Our Role

Advisor to the Board of Directors and management

  • Prepared extensive management presentation materials and compiled electronic data room.
  • Assisted in negotiation of a licensing and distribution agreement with UnilabsSA, a leading medical laboratory headquartered in Geneva in covering certain European and Middle Eastern markets for the introduction of COLOX™ as a ‘self-pay’ screening test.